Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA: 600436)
China
· Delayed Price · Currency is CNY
246.60
+2.01 (0.82%)
Nov 18, 2024, 3:00 PM CST
Zhangzhou Pientzehuang Pharmaceutical., Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 15, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 142,383 | 145,997 | 174,033 | 263,740 | 161,393 | 65,515 | Upgrade
|
Market Cap Growth | -6.08% | -16.11% | -34.01% | 63.41% | 146.34% | 26.80% | Upgrade
|
Enterprise Value | 140,867 | 144,884 | 173,032 | 258,268 | 157,158 | 62,449 | Upgrade
|
Last Close Price | 236.00 | 238.42 | 282.96 | 427.22 | 260.88 | 106.62 | Upgrade
|
PE Ratio | 46.27 | 52.19 | 70.39 | 108.45 | 96.55 | 47.67 | Upgrade
|
Forward PE | 41.22 | 42.87 | 70.44 | 94.42 | 87.42 | 45.96 | Upgrade
|
PS Ratio | 13.06 | 14.51 | 20.02 | 32.88 | 24.79 | 11.45 | Upgrade
|
PB Ratio | 10.15 | 10.49 | 14.72 | 26.02 | 19.55 | 9.40 | Upgrade
|
P/TBV Ratio | 11.35 | 11.16 | 15.81 | 27.81 | 21.23 | 10.12 | Upgrade
|
P/FCF Ratio | 141.33 | 70.71 | 25.98 | 712.61 | 153.99 | - | Upgrade
|
P/OCF Ratio | 138.50 | 66.16 | 25.32 | 570.53 | 110.01 | - | Upgrade
|
PEG Ratio | 2.22 | 2.87 | 2.61 | 2.36 | 1.65 | 1.65 | Upgrade
|
EV/Sales Ratio | 12.91 | 14.40 | 19.90 | 32.20 | 24.14 | 10.91 | Upgrade
|
EV/EBITDA Ratio | 38.77 | 43.93 | 59.73 | 90.50 | 83.51 | 38.66 | Upgrade
|
EV/EBIT Ratio | 40.07 | 44.85 | 60.72 | 93.99 | 87.72 | 40.04 | Upgrade
|
EV/FCF Ratio | 139.82 | 70.17 | 25.83 | 697.82 | 149.95 | - | Upgrade
|
Debt / Equity Ratio | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.10 | Upgrade
|
Debt / EBITDA Ratio | 0.32 | 0.35 | 0.38 | 0.31 | 0.38 | 0.43 | Upgrade
|
Debt / FCF Ratio | 1.17 | 0.56 | 0.17 | 2.39 | 0.69 | - | Upgrade
|
Asset Turnover | 0.64 | 0.63 | 0.64 | 0.71 | 0.68 | 0.74 | Upgrade
|
Inventory Turnover | 1.65 | 1.79 | 1.87 | 1.71 | 1.67 | 1.70 | Upgrade
|
Quick Ratio | 1.36 | 3.91 | 3.85 | 3.70 | 3.23 | 2.84 | Upgrade
|
Current Ratio | 5.12 | 5.24 | 5.06 | 4.98 | 4.61 | 4.21 | Upgrade
|
Return on Equity (ROE) | 22.05% | 22.15% | 22.98% | 26.80% | 22.19% | 22.59% | Upgrade
|
Return on Assets (ROA) | 12.89% | 12.74% | 13.13% | 15.11% | 11.78% | 12.60% | Upgrade
|
Return on Capital (ROIC) | 14.50% | 14.41% | 14.87% | 17.17% | 13.46% | 14.36% | Upgrade
|
Earnings Yield | 2.16% | 1.92% | 1.42% | 0.92% | 1.04% | 2.10% | Upgrade
|
FCF Yield | 0.71% | 1.41% | 3.85% | 0.14% | 0.65% | -1.44% | Upgrade
|
Dividend Yield | 0.98% | 0.97% | 0.44% | 0.28% | 0.34% | 0.77% | Upgrade
|
Payout Ratio | 46.53% | 28.05% | 30.77% | 23.41% | 31.25% | 28.57% | Upgrade
|
Buyback Yield / Dilution | -0.24% | 0.02% | 0.07% | -0.00% | -0.11% | 0.32% | Upgrade
|
Total Shareholder Return | 0.75% | 1.00% | 0.51% | 0.28% | 0.24% | 1.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.